Navigation path

Pharmaceuticals - Community Register


Community register of orphan medicinal products


Product information

Pegylated recombinant factor VIII

EU orphan designation number: EU/3/12/995   
Active ingredient: Pegylated recombinant factor VIII
Indication: Treatment of haemophilia A
Sponsor: Novo Nordisk A/S
Novo Allé, DK-2880 Bagsvaerd, Danmark

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
30/04/2012 Orphan designation EMA/OD/144/11 (2012)2990 of 26/04/2012